Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study will assess the safety and efficacy of adding nateglinide to treatment with basal insulin glargine, metformin and/or thiazolidinedione (pioglitazone or rosiglitazone), for patients with type 2 diabetes who are not achieving glycemic control with glargine, metformin and/or thiazolidinedione only.
Epistemonikos ID: 5e441b3dfdb60199b2268c189204c16fc002529d
First added on: May 04, 2024